Urate transporters in the genomic era

Current Opinion in Nephrology and Hypertension

Volumn 22, Issue 5, 2013, Pages 545-550

  Sakurai, Hiroyuki ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ABCG2; fractional excretion of urate; genome wide association studies; SLC2A9

Indexed keywords

ACETYLSALICYLIC ACID; BREAST CANCER RESISTANCE PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PRAVASTATIN; SODIUM PHOSPHATE COTRANSPORTER; URATE;

CELL STRESS; EXCRETION; GENE MUTATION; GENETIC ASSOCIATION; GENOMICS; HYPERURICEMIA; KIDNEY PROXIMAL TUBULE; MEMBRANE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; REVIEW; SECRETION (PROCESS); SINGLE NUCLEOTIDE POLYMORPHISM; TRANSGENIC MOUSE; URIC ACID BLOOD LEVEL;

EID: 84882448261     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e328363ffc8     Document Type: Review

References (41)

1. Roch-Ramel F, Guisan B. Renal transport of urate in humans. News Physiol Sci 1999; 14:80-84.
2. Enomoto A, Kimura H, Chairoungdua A, et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002; 417:447-452.
3. Li S, Sanna S, Maschio A, et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet 2007; 3:e194.
4. Woodward OM, Kottgen A, Coresh J, et al. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci USA 2009; 106:10338-10342.
5. Dehghan A, Kottgen A, Yang Q, et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 2008; 372:1953-1961.
6. Kottgen A, Albrecht E, Teumer A, et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet 2013; 45:145-154.
7. Sulem P, Gudbjartsson DF, Walters GB, et al. Identification of low-frequency variants associated with gout and serum uric acid levels. Nat Genet 2011; 43:1127-1130.
8. Kolz M, Johnson T, Sanna S, et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 2009; 5:e1000504.
9. Hagos Y, Stein D, Ugele B, et al. Human renal organic anion transporter 4 operates as an asymmetric urate transporter. J Am Soc Nephrol 2007; 18:430-439.
10. Yang Q, Kottgen A, Dehghan A, et al. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet 2010; 3:523-530.
11. Li Z, Ding H, Chen C, et al. Novel URAT1 mutations caused acute renal failure after exercise in two Chinese families with renal hypouricemia. Gene 2013; 512:97-101.
12. Dinour D, Gray NK, Ganon L, et al. URAT1 mutations cause renal hypouricemia type 1 in Iraqi Jews. Nephrol Dialysis Transplant 2011; 26:2175-2181.
13. Ochi A, Takei T, Ichikawa A, et al. A case of acute renal failure after exercise with renal hypouricemia demonstrated compound heterozygous mutations of uric acid transporter 1. Clin Exp Nephrol 2012; 16:316-319.
14. Okada Y, Sim X, Go MJ, et al. Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations. Nat Genet 2012; 44:904-909.
15. Karns R, Zhang G, Sun G, et al. Genome-wide association of serum uric acid concentration: replication of sequence variants in an island population of the Adriatic coast of Croatia. Ann Hum Genet 2012; 76:121-127.
16. Kamatani Y, Matsuda K, Okada Y, et al. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat Genet 2010; 42:210-215.
17. Sull JW, Park EJ, Lee M, Jee SH. Effects of SLC2A9 variants on uric acid levels in a Korean population. Rheumatol Int 2013; 33:19-23.
18. Dinour D, Gray NK, Ganon L, et al. Two novel homozygous SLC2A9 mutations cause renal hypouricemia type. Nephrol Dialysis Transplant 2012; 27:1035-1041.
19. Stiburkova B, Ichida K, Sebesta I. Novel homozygous insertion in SLC2A9 gene caused renal hypouricemia. Mol Genet Metab 2011; 102:430-435.
20. Shima Y, Nozu K, Nozu Y, et al. Recurrent EIARF and PRES with severe renal hypouricemia by compound heterozygous SLC2A9 mutation. Pediatrics 2011; 127:e1621-e1625.
21. Kawamura Y, Matsuo H, Chiba T, et al. Pathogenic GLUT9 mutations causing renal hypouricemia type 2 (RHUC2). Nucleosides Nucleotides Nucleic Acids 2011; 30:1105-1111.
22. Augustin R, Carayannopoulos MO, Dowd LO, et al. Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking. J Biol Chem 2004; 279:16229-16236.
23. Witkowska K, Smith KM, Yao SY, et al. Human SLC2A9a and SLC2A9b isoforms mediate electrogenic transport of urate with different characteristics in the presence of hexoses.AmJ Physiol Renal Physiol 2012; 303:F527-F539.
24. Dalbeth N, House ME, Gamble GD, et al. Population-specific influence of SLC2A9 genotype on the acute hyperuricaemic response to a fructose load. Ann Rheum Dis 2013. [Epub ahead of print]
25. Kimura T, Amonpatumrat S, Tsukada A, et al. Increased expression of SLC2A9 decreases urate excretion from the kidney. Nucleosides Nucleotides Nucleic Acids 2011; 30:1295-1301.
26. Zhou Y, Fang L, Jiang L, et al. Uric acid induces renal inflammation via activating tubular NF-kappaB signaling pathway. PloS One 2012; 7:e39738.
27. Sato M, Wakayama T,Mamada H, et al. Renal secretion of uric acid by organic anion transporter 2 (OAT2/SLC22A7) in human. Biol Pharmaceut Bull 2010; 33:498-503.
28. Jutabha P, Anzai N, Kitamura K, et al. Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate. J Biol Chem 2010; 285:35123-35132.
29. Iharada M, Miyaji T, Fujimoto T, et al. Type 1 sodium-dependent phosphate transporter (SLC17A1 Protein) is a Cl(-)-dependent urate exporter. J Biol Chem 2010; 285:26107-26113.
30. Tin A, Woodward OM, Kao WH, et al. Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele. Hum Mol Genet 2011; 20:4056-4068.
31. Ichida K, Matsuo H, Takada T, et al. Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nat Commun 2012; 3:764.
32. Hosomi A, Nakanishi T, Fujita T, Tamai I. Extra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2. PloS One 2012; 7:e30456.
33. Togawa N, Miyaji T, Izawa S, et al.ANa\+-phosphate cotransporter homologue (SLC17A4 protein) is an intestinal organic anion exporter. Am J Physiol Cell Physiol 2012; 302:C1652-C1660.
34. Hiratochi M, Tatani K, Shimizu K, et al. Hypouricemic effects of novel concentrative nucleoside transporter 2 inhibitors through suppressing intestinal absorption of purine nucleosides. Eur J Pharmacol 2012; 690:183-191.
35. Sakurai H. Transporter-centric view of urate metabolism: from genome wide association study to pathophysiology. J Phys Fitness Sports Med 2012; 1:413-422.
36. Woodward OM, Tukaye DN, Cui J, et al. Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small molecules. Proc Natl Acad Sci USA 2013; 110:5223-5228.
37. Takiue Y, Hosoyamada M, Kimura M, Saito H. The effect of female hormones upon urate transport systems in the mouse kidney. Nucleosides Nucleotides Nucleic Acids 2011; 30:113-119.
38. Jin L, Kikuchi R, Saji T, et al. Regulation of tissue-specific expression of renal organic anion transporters by hepatocyte nuclear factor 1 alpha/beta and DNA methylation. J Pharmacol Exp Ther 2012; 340:648-655.
39. Wang CP, Wang Y, Wang X, et al. Mulberroside A possesses potent uricosuric and nephroprotective effects in hyperuricemic mice. Planta Medica 2011; 77:786-794.
40. Lu Y, Nakanishi T, Tamai I. Functional cooperation of SMCTs and URAT1 for renal reabsorption transport of urate. Drug Metab Pharmacokinet 2013; 28:153-158.
41. Bataille AM, Maffeo CL, Renfro JL. Avian renal proximal tubule urate secretion is inhibited by cellular stress-induced AMP-activated protein kinase. Am J Physiol Renal Physiol 2011; 300:F1327-F1338.